semaglutide fda approval history of glucagon-like peptide-1 receptor agonists fda deadline for semaglutide semaglutide
Description
Some researchers suspect GLP-1 medications may subtly alter the balance of gut bacteria, potentially favoring sulfide-producing strains

Colmers, I

doi:10.1001/jamaophthalmol.2025.1455

The Drug That Won't Stop Eng's discovery proved something critical: targeting the GLP-1 receptor works
Beyond its primary application in diabetes management, semaglutide has also shown promise in the realm of weight loss
